United Capital Financial Advisers, LLC Abiomed Inc Transaction History

United Capital Financial Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$250.96 - $284.94 $189,976 - $215,699	-757 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$276.39 - $362.25 $17,412 - $22,821	-63 Reduced 7.68%	757 $216,000
Q4 2018 Feb 14, 2019	BUY	$281.08 - $444.25 $38,507 - $60,862	137 Added 20.06%	820 $267,000
Q3 2018 Nov 14, 2018	BUY	$354.53 - $449.75 $21,626 - $27,434	61 Added 9.81%	683 $307,000
Q2 2018 Aug 14, 2018	BUY	$278.07 - $446.21 $172,959 - $277,542	622 New	622 $254,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on United Capital Financial Advisers, LLC with notifications on news.